IP Verse

Method For Determining Total Histamine Degradation Capacity In Biological Samples - EP3752838

The patent EP3752838 was granted to Frost Diagnostika on Aug 3, 2022. The application was originally filed on Feb 15, 2019 under application number EP19709626A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3752838

FROST DIAGNOSTIKA
Application Number
EP19709626A
Filing Date
Feb 15, 2019
Status
Granted And Under Opposition
Jul 1, 2022
Grant Date
Aug 3, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

IMMUNDIAGNOSTIKMay 1, 2023BENEDUMADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONAT411688B
DESCRIPTIONEP1948819
INTERNATIONAL-SEARCH-REPORTWO2007056788
OPPOSITIONAT502850B
OPPOSITIONEP0208953
OTHERAT502850B
OTHEREP1948819

Non-Patent Literature (NPL) Citations (17) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
EXAMINATION- C Reiser ET AL, "Assessment and topographical analysis of the total histamine degradation capacity (THDC) at the lower GI-tract", ZEITSCHRIFT FUER GASTROENTEROLOGIE, DE, (20130816), vol. 51, no. 08, doi:10.1055/s-0033-1352932, ISSN 0044-2771, XP055579766
INTERNATIONAL-SEARCH-REPORT- MOREL A M ET AL, "IMMUNOANALYSIS OF HISTAMINE THROUGH A NOVEL CHEMICAL DERIVATIZATION", JOURNAL OF ALLERGY AND CLINICAL IMMUNO, ELSEVIER, AMSTERDAM, NL, (19881001), vol. 82, no. 4, doi:10.1016/0091-6749(88)90978-5, ISSN 0091-6749, pages 646 - 654, XP009080391 [I] 12 * the whole document * [A] 1-11
INTERNATIONAL-SEARCH-REPORT- PFISTERER M ET AL, "New diagnostic and treatment opportunities of food-intolerance caused by histamine: first clinical results", ALL, WILEY-BLACKWELL PUBLISHING LTD, UNITED KINGDOM, vol. 62, no. Suppl. 83, doi:10.1111/J.1398-9995.2007.01407.X, ISSN 0105-4538, (20070601), page 333, (20070525), XP009156956 [A] 1-12
OPPOSITION- Arunlakshana O, Et Al, "Potentiation of pharmacological effects of Histamine by histaminase Inhibitors", J. Physiol., (19540101), vol. 123, pages 32 - 54, XP093053837
OPPOSITION- Best C H, Mchenry E W, "The inactivation of Histamine", J. Physiol., (19300101), vol. 70, no. 4, pages 349 - 372, XP093053839
OPPOSITION- DELAAGE M et al., "Dosage de l'histamine: utilisation d'un anticorps monoclonal pour un radioimmunoessai et un enzymoimmunoessai", Allergie et Immunologie, (19880000), vol. 20, no. 9, pages 333 - 335, XP009080392
OPPOSITION- KUEFNER M.A. et al., "Determination of histamine degradation capacity in extremely small human colon samples", Materials and Methods, page S96, XP055852318
OPPOSITION- KUEFNER M.A. et al., "Total histamine degradation capacity (THDC) as an important biological marker of histamine metabolism in human colonic mucosa", Inflamm. Res., (20020000), vol. 51, no. 1, pages S87 - S88, XP009512561
OPPOSITION- MAINTZ LAURA, NOVAK N, "Histamine and histamine intolerance.", American Journal of Clinical Nutrition, (20070501), vol. 85, no. 5, ISSN 0002-9165, pages 1185 - 1196, XP002466268
OPPOSITION- Morgan D J, Et Al, "Plasma histamine in asthmatic and control subjects following exercise: influence of basophils and different assay techniques", Thorax, (19830101), vol. 38, pages 771 - 777, XP093053826
OPPOSITION- RAITHEL M et al., "The involvement of the histamine degradation pathway by diamine oxidase in manifest gastrointestinal allergies", Inflamm Res, (19990000), vol. 48, no. 1, page S75, XP055852303
OPPOSITION- Reese Imke, Et Al, "Vorgehen bei Verdacht aufUnverträglichkeit gegenüber oralaufgenommenem Histamin", Allergo J, (20120101), vol. 21, no. 1, pages 22 - 28, XP093053834
OPPOSITION- Rosell-Camps Antonio, Et Al, "Histamine intolerance as a cause of chronic digestive complaints in pediatric patients", Revista Espanola de Enfermedades Digestivas, (20130101), vol. 105, no. 4, pages 201 - 207, XP093053829
OPPOSITION- MOREL AM et al., "Immunoanalysis of histamine through a novel chemical derivatization", J. Allergy Clin. Immunol., (19880000), vol. 84, no. 4, doi:10.1016/0091-6749(88)90978-5, pages 646 - 54, XP009080391
OTHER- KUEFNER M.A. et al., "Determination of histamine degradation capacity in extremely small human colon samples", Inflamm Res, (20010000), vol. 50, no. Suppl. 2, pages S96 - S97, XP055852318
OTHER- KUEFNER M.A. et al., "Total histamine degradation capacity (THDC) as an important biological marker of histamine metabolism in human colonic mucosa", Inflamm. Res., (20020000), vol. 51, pages S87 - S88, XP009512561
OTHER- RAITHEL M et al., "The involvement of the histamine degradation pathway by diamine oxidase in manifest gastrointestinal allergies", Inflamm Res, (19990000), vol. 48, no. Suppl.1, pages S75 - S76, XP055852303

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents